Changeflow GovPing Healthcare Philips Trilogy EV300 Recall - Tidal Volume Dis...
Urgent Enforcement Added Final

Philips Trilogy EV300 Recall - Tidal Volume Discrepancy Risk

Favicon for changeflow.com FDA: Device Recalls Class I
Filed April 1st, 2026
Detected April 7th, 2026
Email

Summary

The FDA issued a Class I recall (Z-1616-2026) for Philips Respironics Trilogy EV300 ventilators running Software Version 1.05.15.00 due to tidal volume discrepancies when non-pneumatic nebulizers are used. The recall affects devices distributed both domestically and internationally. Philips is notifying customers of the safety issue and providing guidance on mitigating the risk.

What changed

Philips Respironics initiated a Class I recall for Trilogy EV300 continuous home-use ventilators (Software Version 1.05.15.00) after discovering that using non-pneumatic nebulizers with these devices may result in a discrepancy between the set tidal volume and the tidal volume actually delivered to the patient. Class I is the most serious recall classification, indicating reasonable probability of serious adverse health consequences or death. The recall affects devices distributed worldwide, including throughout the US.

Healthcare providers and durable medical equipment suppliers should immediately identify any Trilogy EV300 devices in use or inventory, notify patients and caregivers of the tidal volume discrepancy risk when non-pneumatic nebulizers are co-used, and contact Philips Respironics for replacement options or repair instructions. Patients should not stop using their ventilator without consulting their healthcare provider. The recall is ongoing, and Philips is expected to provide further instructions through their customer notification process.

What to do next

  1. Identify all Trilogy EV300 ventilators (Software Version 1.05.15.00) in clinical or home use
  2. Notify patients and caregivers of tidal volume discrepancy risk when non-pneumatic nebulizers are co-used with Trilogy EV300 devices
  3. Contact Philips Respironics for repair/replacement options and follow recall-specific guidance

Source document (simplified)

Philips Respironics, Inc.

Device Recalls (Class I)

← All Device Recalls (Class I) Class I Z-1616-2026 · 20260401 · Ongoing

Product

Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device.

Reason for Recall

Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.

Distribution

Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgi...

Source: openFDA Enforcement API

Named provisions

Class I Device Recall Trilogy EV300

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
April 1st, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1616-2026

Who this affects

Applies to
Medical device makers Healthcare providers Patients
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recall Ventilator Safety Monitoring
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Topics
Product Safety Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class I publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.